BDENZA Enzalutamide Tablets 80 mg – Advanced Therapy for Prostate Cancer Brand: BDENZA Generic Name: Enzalutamide Strength: 80 mg Form: Oral Tablets Manufacturer: BDR Pharmaceuticals Availability: In Stock | Ships Worldwide Exported by: Unnati Pharmax Product Overview BDENZA Enzalutamide Tablets 80 mg is a highly effective oral therapy used in the treatment of metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). It is widely prescribed for men whose prostate cancer continues to progress despite androgen deprivation therapy (ADT). BDENZA works by inhibiting androgen receptor signaling, thereby blocking the effects of male hormones such as testosterone, which fuel the growth and spread of prostate cancer cells. This results in slowing disease progression, improving overall survival, and enhancing patient quality of life. Why Choose BDENZA Enzalutamide 80 mg? ✅ Clinically proven for both mCRPC and mHSPC treatment ✅ Potent androgen receptor inhibitor for advanced disease control ✅ Oral tablet formulation for ease and convenience ✅ Backed by oncologists worldwide and part of standard care guidelines ✅ Effective therapy with demonstrated survival benefits How It Works Enzalutamide in BDENZA is a next-generation androgen receptor inhibitor. It prevents androgen binding, receptor activation, and nuclear translocation. By blocking this critical signaling pathway, BDENZA deprives prostate cancer cells of the stimuli they need to grow and survive. Composition Each tablet contains: Enzalutamide 80 mg Dosage and Administration Take BDENZA exactly as prescribed by your oncologist Standard recommended dose: 160 mg once daily (two 80 mg tablets) Can be taken with or without food Swallow the tablets whole with water Buy BDENZA Enzalutamide 80 mg Online Looking for genuine and affordable Enzalutamide tablets online? Order BDENZA 80 mg today from Unnati Pharmax, your trusted exporter of oncology and specialty medicines. We provide: ✅ 100% authentic and high-quality products ✅ Fast and secure global delivery ✅ Discreet packaging for patient privacy ✅ Competitive pricing for both retail and bulk orders FAQs – BDENZA Enzalutamide Tablets 80 mg Q1: What conditions is BDENZA prescribed for? A1: BDENZA is prescribed for metastatic castration-resistant prostate cancer (mCRPC) and metastatic hormone-sensitive prostate cancer (mHSPC). Q2: How is BDENZA usually taken? A2: The standard dose is 160 mg once daily (two 80 mg tablets), or as directed by your oncologist. Q3: When do patients usually see benefits? A3: Many patients notice improvements within weeks to months, depending on individual response. Oncologists monitor PSA levels and overall progress during treatment.